COURT-RULING ·Filed Feb 12, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 4/10
Horizonimmediate Processed3mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

The document content was unavailable, so the significance of this court ruling cannot be determined from the filing alone. Monitor for the full order or a subsequent 8-K that may disclose a material judgment or settlement. Until then, treat this as a low-visibility procedural development.

DirectionNeutral
Confidencelow
Horizonimmediate
Final — all horizons settled through T+60d
MRK ▼ -6.68% at T+60d
NEUTRAL call ✗ call lost -6.68% · α vs SPY -15.19% · entry $119.24 → $111.28
Entry anchored
Feb 11, 03:59 PM ET
via exchange tick
T+1d
+1.82%
call +1.82% · α +1.75%
$121.41
settled 8mo ago
T+5d
+2.53%
call +2.53% · α +1.33%
$122.26
settled 8mo ago
T+20d
-3.04%
call -3.04% · α -0.26%
$115.61
settled 7mo ago
T+60d
-6.68%
call -6.68% · α -15.19%
$111.28
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Kaiser Foundation Health Plan, Inc. won a ruling in its lawsuit against Merck & Co., Inc. in the Northern District of California. The opinion text was provided but the specific ruling type, outcome, and financial exposure were not detailed in the available document content. The filing metadata indicates a district court decision in an ongoing case, but without the full opinion text, the magnitude and direction of the impact on Merck remain unclear.

Court Ruling Details

Ruling Date
Feb 12, 2026
Court
U.S. District Court for the Northern District of California
Court Level
District
Case Type
other
Ruling Type
other
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • Lawsuit: Kaiser Foundation Health Plan, Inc. v. Merck & Co., Inc. et al., filed in N.D. California on 2026-02-12
  • Even though it was previously reported in 2026-02-12, this filing is a district court ruling/order in that case
  • Document content was unavailable — ruling type (e.g. motion to dismiss, summary judgment) and outcome not extractable

Financial Impact

Not determinable — no damages figure, injunction details, or settlement amount stated in provided document

litigation_expenselegal_liabilityoperational_risk

Risk Factors

  • Adverse ruling could impose damages or injunctive relief on a Merck product or business practice
  • Uncertainty over outcome and size of potential financial exposure

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-1ojan1sx-MRK
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.57 (−0.25%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.57 (−2.68%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.57 (−3.99%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.57 (+4.71%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.57 (−3.64%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.57 (+5.69%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.57 (+5.92%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.57 (+5.92%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.57 (+8.01%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.57 (+8.01%)
Showing 10 of 20

US Market Status

Market Open — Closes in 6h 23m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access